Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2021-12-08 00:00:00 ET · period of report 2021-12-06 · accession 0001567619-21-021768 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-08 | 2021-12-06 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +37.7K | 84.2K | +81% | +$18.5K |
| D | 2021-12-08 | 2021-12-06 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -37.7K | 167.8K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-06 | M | A | 37,721 | $0.49 | 84,193 | D | — | — | (F4) Includes 42,000 RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-06 | M | D | 37,721 | $0.00 | 167,782 | D | $0.49 · 2020-12-01 to 2027-03-20 | 37,721 Common Stock |